Published July 15, 2001 | Version v1
Journal article

Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method

Description

Purpose: To examine the acute urinary toxicity following transperineal prostate implant using a modified Quimby loading method with regard to time course, severity, and factors that may be associated with a higher incidence of morbidity. Methods and Materials: One hundred thirty-nine patients with prostate adenocarcinoma treated with brachytherapy from 1997 through 1999 had follow-up records available for review. Patients considered for definitive brachytherapy alone included those with prostate specific antigen (PSA) ≤6, Gleason score (GS) ≤6, clinical stage 6, PSA>6, or Stage>T2a were treated with external beam radiation therapy followed by brachytherapy boost. Sources were loaded according to a modified Quimby method. At each follow-up, toxicity was graded based on a modified RTOG urinary toxicity scale. Results: Acute urinary toxicity occurred in 88%. Grade I toxicity was reported in 23%, grade II in 45%, and grade III in 20%, with 14% requiring prolonged (greater than 1 week) intermittent or indwelling catheterization. Overall median duration of symptoms was 12 months. There was no difference in duration of symptoms between patients treated with I-125 or Pd-103 sources (p=0.71). After adjusting for GS and PSA, multivariate logistic regression analysis showed higher incidence of grade 3 toxicity in patients with larger prostate volumes (p=0.002), and those with more seeds implanted (p<0.001). Higher incidence of prolonged catheterization was found in patients receiving brachytherapy alone (p=0.01), with larger prostate volumes (p=0.01), and those with more seeds implanted (p<0.001). Conclusion: Interstitial brachytherapy for prostate cancer leads to a high incidence of acute urinary toxicity, most of which is mild to moderate in severity. A prolonged need for catheterization can occur in some patients. Patients receiving brachytherapy alone, those with prostate volumes greater than 30 cc, and those implanted with a greater number of seeds have the highest incidence of significant toxicity

Additional details

Identifiers

PII
S0360301601015309;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
50
Journal Issue
4
Journal Page Range
p. 937-945
ISSN
0360-3016
CODEN
IOBPD3

Optional Information

Copyright
Copyright (c) 2001 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.